
Jan 31 (Reuters) - Vertex Pharmaceuticals Inc VRTX.O:
VERTEX ANNOUNCES CASGEVY® REIMBURSEMENT AGREEMENT FOR THE TREATMENT OF SICKLE CELL DISEASE IN ENGLAND
VERTEX ANNOUNCES CASGEVY® REIMBURSEMENT AGREEMENT FOR THE TREATMENT OF SICKLE CELL DISEASE IN ENGLAND
VERTEX PHARMACEUTICALS INC - NICE ISSUES POSITIVE GUIDANCE FOR CASGEVY USE IN NHS
Source text: ID:nBwqXsBa
Further company coverage: VRTX.O